Lenalidomide 15mg capsules
NHS hospitals in England used £58,586,373 of indicative cost of Lenalidomide 15mg capsules in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 9.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Lenalidomide 15mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Lenalidomide 15mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Colchester Hospital University Nhs Ft | £1,540,599 |
| University College London Foundation Tr | £1,524,758 |
| University Hospital Southampton Nhs Ft | £1,474,200 |
| Western Sussex Hospitals Nhs Found Trust | £1,401,435 |
| Southend Univ Hosp Nhs Foundation Trust | £1,316,007 |
| South Tyneside And Sunderland Nhs Ft | £1,256,661 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,226,043 |
| Worcestershire Acute Hpls Nhs Trust | £1,150,821 |
| The Clatterbridge Cancer Centre Nhs Ft | £1,139,670 |
| Oxford University Hospitals Nhs Ft | £1,000,566 |
The primary-care picture
Lenalidomide is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Lenalidomide medicine page.